Pharmaceutical Investing Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan
Biotech Investing Kura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update
Biotech Investing Onconova Therapeutics Announces Pricing of $25.0 Million Upsized Underwritten Public Offering
Biotech Investing Moleculin Enters Agreement with BSP Pharmaceuticals for its Leukemia Drug Candidate
Pharmaceutical Investing Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
Pharmaceutical Investing VBL Therapeutics Presents Late Breaking Research Demonstrating Immune-cell Mediated Killing of Cancer Cells by a Novel Bi-specific Antibody at AACR
Pharmaceutical Investing Moleculin Announces Patients Treated in FDA Approved Phase I/II Annamycin Clinical Trial
Pharmaceutical Investing Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials
Pharmaceutical Investing Moleculin Announces Grant-Funded Collaboration to Expand Understanding of New Discovery
Pharmaceutical Investing Dova Pharmaceuticals Signs Exclusive Distribution Agreement with Fosun Pharma For Mainland China and Hong Kong